Create Free Account

By creating account you will get access to hot stocks & personalised emails

Oscar Health Inc

Healthcare US OSCR

18.3USD
0.49(2.75%)

Last update at 2024-08-30T20:10:00Z

Day Range

17.8318.47
LowHigh

52 Week Range

2.119.89
LowHigh

Fundamentals

  • Previous Close 17.81
  • Market Cap2037.26M
  • Volume2156906
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-285.92998M
  • Revenue TTM5441.12M
  • Revenue Per Share TTM24.88
  • Gross Profit TTM 707.87M
  • Diluted EPS TTM-1.6

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -610.07500M -570.58000M -405.78000M -259.38900M
Minority interest 3.28M -1.18000M - 0.00000M
Net income -609.55200M -571.42600M -406.82500M -261.18200M
Selling general administrative 309.78M 265.08M 166.66M 110.68M
Selling and marketing expenses - - - -
Gross profit 4125.58M 1920.96M 589.64M 553.78M
Reconciled depreciation 15.28M 14.61M 11.29M 6.90M
Ebit -584.17500M -577.06000M -406.86400M -260.46400M
Ebitda -568.89200M -562.45500M -395.57900M -253.56500M
Depreciation and amortization 15.28M 14.61M 11.29M 6.90M
Non operating income net other - -21.37900M - -
Operating income -584.17500M -577.06000M -406.86400M -260.46400M
Other operating expenses 4735.66M 2491.54M 995.42M 813.17M
Interest expense 22.62M 4.72M 3.51M 0.00000M
Tax provision -0.52300M 0.85M 1.04M 1.79M
Interest income 31.31M 10.25M 8.01M 11.12M
Net interest income -22.62300M -4.72000M -3.51400M 0.00000M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -0.52300M 0.85M 1.04M 1.79M
Total revenue 4125.58M 1920.96M 589.64M 553.78M
Total operating expenses 4553.51M -2498.02100M -996.50500M -814.24300M
Cost of revenue - - - -
Total other income expense net -25.90000M 6.48M 1.08M 1.07M
Discontinued operations - - - -
Net income from continuing ops -609.55200M -571.42600M -406.82500M -261.18200M
Net income applicable to common shares -606.27500M -572.60600M -406.82500M -261.18200M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4526.60M 3321.65M 2272.11M 1346.91M
Intangible assets - - - -
Earning assets - - - -
Other current assets 1165.67M 614.85M 581.25M 517.51M
Total liab 3634.20M 440.02M 3568.00M 494.24M
Total stockholder equity 890.38M 1387.23M -1295.89300M -945.13800M
Deferred long term liab - - - -
Other current liab 2538.43M -440.01900M -480.83700M -494.23500M
Common stock 0.00200M 0.00200M 0.00200M 0.00200M
Capital stock 0.00200M 0.00200M 0.00200M 0.00200M
Retained earnings -2605.98700M -1999.71200M -1427.10600M -1012.86300M
Other liab 0.10M 76.84M 15.01M 8.82M
Good will - - - -
Other assets 4526.60M 817.80M 580.72M 254.50M
Cash 1558.60M 1103.99M 826.33M 336.64M
Cash and equivalents - - - -
Total current liabilities 3263.92M 440.02M 480.84M 494.24M
Current deferred revenue - - - -
Net debt -1260.59600M -1103.99500M -683.83900M -336.64400M
Short term debt - - - -
Short long term debt - - - -
Short long term debt total 298.00M 297.42M 142.49M -
Other stockholder equity 3506.08M 68.96M 130.33M 67.75M
Property plant equipment 59.89M 46.61M 35.81M 33.08M
Total current assets 4121.56M 1870.15M 1289.19M 725.59M
Long term investments 1397.29M 587.09M 366.39M 333.75M
Net tangible assets 890.38M 1387.23M -1295.89300M -945.13800M
Short term investments 1397.29M 587.09M 366.39M 333.75M
Net receivables 1159.22M 179.07M 96.48M 55.19M
Long term debt 298.00M - 142.49M -
Inventory -1159.22300M -614.84500M - -
Accounts payable 725.49M 440.02M 480.84M 494.24M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity 2.02M 5.29M - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -9.71500M -3.67100M 0.88M -0.02700M
Additional paid in capital - - - -
Common stock total equity 0.00200M 0.00200M 0.00200M 0.00200M
Preferred stock total equity - - - -
Retained earnings total equity -2605.98700M -1999.71200M - -
Treasury stock -2.92300M -2.92300M - -
Accumulated amortization - - - -
Non currrent assets other -1052.12900M -633.69700M -402.19900M -366.82900M
Deferred long term asset charges - - - -
Non current assets total 405.05M 633.70M 402.20M 366.83M
Capital lease obligations - - - -
Long term debt total 298.00M - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -226.51900M -755.30500M -329.45000M 183.59M
Change to liabilities 259.15M 101.76M 122.40M 13.02M
Total cashflows from investing activities -226.51900M -774.51500M -344.71400M 150.51M
Net borrowings 297.96M -153.17300M 147.00M 147.00M
Total cash from financing activities 301.11M 1238.71M 611.71M -2.11900M
Change to operating activities 874.28M 212.89M 488.56M 57.79M
Net income -609.55200M -571.42600M -406.82500M -261.18200M
Change in cash 454.94M 282.45M 489.73M -16.97600M
Begin period cash flow 1125.56M 843.11M 353.38M 370.36M
End period cash flow 1580.50M 1125.56M 843.11M 353.38M
Total cash from operating activities 380.35M -181.74500M 222.73M -165.37000M
Issuance of capital stock 0.00000M 1348.32M 375.67M 0.00000M
Depreciation 15.28M 14.61M 11.29M 6.90M
Other cashflows from investing activities 1.12M 6.67M -1.24300M -7.07700M
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables -538.95800M 80.45M -98.58300M -314.31700M
Sale purchase of stock 3.15M 1404.88M 0.00000M -2.99200M
Other cashflows from financing activities 299.81M 43.56M 611.71M 0.87M
Change to netincome 113.44M 128.23M 42.24M 26.71M
Capital expenditures 29.01M 25.89M 14.02M 26.00M
Change receivables -538.95800M 78.53M - -
Cash flows other operating 1137.80M 260.81M - -
Exchange rate changes - - - -
Cash and cash equivalents changes 454.94M 282.45M - -
Change in working capital 857.99M 247.70M 575.70M 62.21M
Stock based compensation 112.33M 86.30M 35.87M 33.56M
Other non cash items 4.47M 41.19M 6.77M -6.42600M
Free cash flow 351.34M -207.63000M 208.71M -191.36600M

Peer Comparison

Sector: Healthcare Industry: Healthcare Plans

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OSCR
Oscar Health Inc		 0.49 2.75% 18.30 - - 0.37 1.98 0.13 -
UNH
UnitedHealth Group Incorporated		 -1.37 0.23% 590.20 22.57 18.38 1.33 5.65 1.38 13.97
ELV
Elevance Health Inc		 4.80 0.87% 556.89 18.00 12.66 0.65 2.87 0.74 -
CVS
CVS Health Corp		 0.27 0.47% 57.24 12.06 9.08 0.29 1.34 0.47 8.96
CI
Cigna Corp		 0.75 0.21% 361.81 16.80 10.45 0.46 1.90 0.58 -

Reports Covered

Stock Research & News

View All

Profile

Oscar Health, Inc. operates as a health insurance in the United States. The company offers Individual and Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payors directly enable their shift to value-based care It also provides reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Oscar Health Inc

75 Varick Street, New York, NY, United States, 10013

Key Executives

Name Title Year Born
Mr. Mario Tobias Schlosser Co-Founder, CEO & Director 1979
Mr. Joshua Kushner Co-Founder & Vice Chairman 1985
Mr. Siddhartha Sankaran Interim CFO & Director 1978
Mr. Richard Scott Blackley CPA, CPA Chief Transformation Officer 1968
Ms. Alessandrea Corinne Quane Exec. VP & Chief Insurance Officer 1970
Ms. Victoria Baltrus Chief Accounting Officer 1970
Cornelia Miller VP of Investor Relations NA
Ms. Ranmali Bopitiya Chief Legal Officer NA
Mr. Joel I. Klein Sr. Advisor 1947
Dr. Dennis Weaver M.D. Chief Clinical Officer 1961

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2024 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.